Life sciences companies falling behind? – Healthcare Economist
That’s what a PwC analysis findsat least as far as stock market returns are concerned. Our PwC Equal-Weighted Index of 50 Pharmaceutical Companies looks at the industry’s total shareholder returns relative to the S&P 500 Equal-Weighted Index. From 2018 through November 2024, the PwC Pharmaceuticals